YARROW BIOSCIENCE, INC. Additional Paid in Capital, Common Stock
YARROW BIOSCIENCE, INC. (YARW) had Additional Paid in Capital, Common Stock of $252.82 million as of 2019-12-31, per its 10-K filed 2020-03-03.
Discontinued › Balance Sheet › Equity
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2020-03-03
- 2019-12-31: Additional Paid in Capital, Common Stock $252.82M.
- 2019-09-30: Additional Paid in Capital, Common Stock $249.81M.
- 2019-06-30: Additional Paid in Capital, Common Stock $248.16M.
- 2019-03-31: Additional Paid in Capital, Common Stock $245.15M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2019-12-31 | $252.82M 10-K · filed 2020-03-03 |
| 2019-09-30 | $249.81M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $248.16M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $245.15M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $241.11M 10-K · filed 2020-03-03 |
| 2018-09-30 | $240.02M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $238.53M 10-Q · filed 2018-08-01 |
| 2017-12-31 | $2.21M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |